Vascular Stent-Europe Market Status and Trend Report 2013-2023
Report Summary
Vascular Stent-Europe Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Vascular Stent industry, standing on the readers’ perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole Europe and Regional Market Size of Vascular Stent 2013-2017, and development forecast 2018-2023
Main market players of Vascular Stent in Europe, with company and product introduction, position in the Vascular Stent market
Market status and development trend of Vascular Stent by types and applications
Cost and profit status of Vascular Stent, and marketing status
Market growth drivers and challenges
The report segments the Europe Vascular Stent market as:
Europe Vascular Stent Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
Germany
United Kingdom
France
Italy
Spain
Benelux
Russia
Europe Vascular Stent Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
BMS
BVS
Drug Eluting
Europe Vascular Stent Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Hospital
Cardiology Center
ASC
Europe Vascular Stent Market: Players Segment Analysis (Company and Product introduction, Vascular Stent Sales Volume, Revenue, Price and Gross Margin):
Medtronic
Abbott Laboratories
Boston Scientific Corporation
BIOTRONIK
B. Braun Melsungen
Terumo Corporation
STENTYS
MicroPort Scientific Corporation
Meril Life Sciences
Vascular Concepts
W. L. Gore and Associates
C. R. Bard
Endologix
Lombard Medical Technologies
Translumina
JOTEC
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Vascular Stent-Europe Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Vascular Stent industry, standing on the readers’ perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole Europe and Regional Market Size of Vascular Stent 2013-2017, and development forecast 2018-2023
Main market players of Vascular Stent in Europe, with company and product introduction, position in the Vascular Stent market
Market status and development trend of Vascular Stent by types and applications
Cost and profit status of Vascular Stent, and marketing status
Market growth drivers and challenges
The report segments the Europe Vascular Stent market as:
Europe Vascular Stent Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
Germany
United Kingdom
France
Italy
Spain
Benelux
Russia
Europe Vascular Stent Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
BMS
BVS
Drug Eluting
Europe Vascular Stent Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Hospital
Cardiology Center
ASC
Europe Vascular Stent Market: Players Segment Analysis (Company and Product introduction, Vascular Stent Sales Volume, Revenue, Price and Gross Margin):
Medtronic
Abbott Laboratories
Boston Scientific Corporation
BIOTRONIK
B. Braun Melsungen
Terumo Corporation
STENTYS
MicroPort Scientific Corporation
Meril Life Sciences
Vascular Concepts
W. L. Gore and Associates
C. R. Bard
Endologix
Lombard Medical Technologies
Translumina
JOTEC
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF VASCULAR STENT
1.1 Definition of Vascular Stent in This Report
1.2 Commercial Types of Vascular Stent
1.2.1 BMS
1.2.2 BVS
1.2.3 Drug Eluting
1.3 Downstream Application of Vascular Stent
1.3.1 Hospital
1.3.2 Cardiology Center
1.3.3 ASC
1.4 Development History of Vascular Stent
1.5 Market Status and Trend of Vascular Stent 2013-2023
1.5.1 Europe Vascular Stent Market Status and Trend 2013-2023
1.5.2 Regional Vascular Stent Market Status and Trend 2013-2023
CHAPTER 2 EUROPE MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of Vascular Stent in Europe 2013-2017
2.2 Consumption Market of Vascular Stent in Europe by Regions
2.2.1 Consumption Volume of Vascular Stent in Europe by Regions
2.2.2 Revenue of Vascular Stent in Europe by Regions
2.3 Market Analysis of Vascular Stent in Europe by Regions
2.3.1 Market Analysis of Vascular Stent in Germany 2013-2017
2.3.2 Market Analysis of Vascular Stent in United Kingdom 2013-2017
2.3.3 Market Analysis of Vascular Stent in France 2013-2017
2.3.4 Market Analysis of Vascular Stent in Italy 2013-2017
2.3.5 Market Analysis of Vascular Stent in Spain 2013-2017
2.3.6 Market Analysis of Vascular Stent in Benelux 2013-2017
2.3.7 Market Analysis of Vascular Stent in Russia 2013-2017
2.4 Market Development Forecast of Vascular Stent in Europe 2018-2023
2.4.1 Market Development Forecast of Vascular Stent in Europe 2018-2023
2.4.2 Market Development Forecast of Vascular Stent by Regions 2018-2023
CHAPTER 3 EUROPE MARKET STATUS AND FORECAST BY TYPES
3.1 Whole Europe Market Status by Types
3.1.1 Consumption Volume of Vascular Stent in Europe by Types
3.1.2 Revenue of Vascular Stent in Europe by Types
3.2 Europe Market Status by Types in Major Countries
3.2.1 Market Status by Types in Germany
3.2.2 Market Status by Types in United Kingdom
3.2.3 Market Status by Types in France
3.2.4 Market Status by Types in Italy
3.2.5 Market Status by Types in Spain
3.2.6 Market Status by Types in Benelux
3.2.7 Market Status by Types in Russia
3.3 Market Forecast of Vascular Stent in Europe by Types
CHAPTER 4 EUROPE MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Vascular Stent in Europe by Downstream Industry
4.2 Demand Volume of Vascular Stent by Downstream Industry in Major Countries
4.2.1 Demand Volume of Vascular Stent by Downstream Industry in Germany
4.2.2 Demand Volume of Vascular Stent by Downstream Industry in United Kingdom
4.2.3 Demand Volume of Vascular Stent by Downstream Industry in France
4.2.4 Demand Volume of Vascular Stent by Downstream Industry in Italy
4.2.5 Demand Volume of Vascular Stent by Downstream Industry in Spain
4.2.6 Demand Volume of Vascular Stent by Downstream Industry in Benelux
4.2.7 Demand Volume of Vascular Stent by Downstream Industry in Russia
4.3 Market Forecast of Vascular Stent in Europe by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF VASCULAR STENT
5.1 Europe Economy Situation and Trend Overview
5.2 Vascular Stent Downstream Industry Situation and Trend Overview
CHAPTER 6 VASCULAR STENT MARKET COMPETITION STATUS BY MAJOR PLAYERS IN EUROPE
6.1 Sales Volume of Vascular Stent in Europe by Major Players
6.2 Revenue of Vascular Stent in Europe by Major Players
6.3 Basic Information of Vascular Stent by Major Players
6.3.1 Headquarters Location and Established Time of Vascular Stent Major Players
6.3.2 Employees and Revenue Level of Vascular Stent Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 VASCULAR STENT MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Medtronic
7.1.1 Company profile
7.1.2 Representative Vascular Stent Product
7.1.3 Vascular Stent Sales, Revenue, Price and Gross Margin of Medtronic
7.2 Abbott Laboratories
7.2.1 Company profile
7.2.2 Representative Vascular Stent Product
7.2.3 Vascular Stent Sales, Revenue, Price and Gross Margin of Abbott Laboratories
7.3 Boston Scientific Corporation
7.3.1 Company profile
7.3.2 Representative Vascular Stent Product
7.3.3 Vascular Stent Sales, Revenue, Price and Gross Margin of Boston Scientific Corporation
7.4 BIOTRONIK
7.4.1 Company profile
7.4.2 Representative Vascular Stent Product
7.4.3 Vascular Stent Sales, Revenue, Price and Gross Margin of BIOTRONIK
7.5 B. Braun Melsungen
7.5.1 Company profile
7.5.2 Representative Vascular Stent Product
7.5.3 Vascular Stent Sales, Revenue, Price and Gross Margin of B. Braun Melsungen
7.6 Terumo Corporation
7.6.1 Company profile
7.6.2 Representative Vascular Stent Product
7.6.3 Vascular Stent Sales, Revenue, Price and Gross Margin of Terumo Corporation
7.7 STENTYS
7.7.1 Company profile
7.7.2 Representative Vascular Stent Product
7.7.3 Vascular Stent Sales, Revenue, Price and Gross Margin of STENTYS
7.8 MicroPort Scientific Corporation
7.8.1 Company profile
7.8.2 Representative Vascular Stent Product
7.8.3 Vascular Stent Sales, Revenue, Price and Gross Margin of MicroPort Scientific Corporation
7.9 Meril Life Sciences
7.9.1 Company profile
7.9.2 Representative Vascular Stent Product
7.9.3 Vascular Stent Sales, Revenue, Price and Gross Margin of Meril Life Sciences
7.10 Vascular Concepts
7.10.1 Company profile
7.10.2 Representative Vascular Stent Product
7.10.3 Vascular Stent Sales, Revenue, Price and Gross Margin of Vascular Concepts
7.11 W. L. Gore and Associates
7.11.1 Company profile
7.11.2 Representative Vascular Stent Product
7.11.3 Vascular Stent Sales, Revenue, Price and Gross Margin of W. L. Gore and Associates
7.12 C. R. Bard
7.12.1 Company profile
7.12.2 Representative Vascular Stent Product
7.12.3 Vascular Stent Sales, Revenue, Price and Gross Margin of C. R. Bard
7.13 Endologix
7.13.1 Company profile
7.13.2 Representative Vascular Stent Product
7.13.3 Vascular Stent Sales, Revenue, Price and Gross Margin of Endologix
7.14 Lombard Medical Technologies
7.14.1 Company profile
7.14.2 Representative Vascular Stent Product
7.14.3 Vascular Stent Sales, Revenue, Price and Gross Margin of Lombard Medical Technologies
7.15 Translumina
7.15.1 Company profile
7.15.2 Representative Vascular Stent Product
7.15.3 Vascular Stent Sales, Revenue, Price and Gross Margin of Translumina
7.16 JOTEC
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF VASCULAR STENT
8.1 Industry Chain of Vascular Stent
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF VASCULAR STENT
9.1 Cost Structure Analysis of Vascular Stent
9.2 Raw Materials Cost Analysis of Vascular Stent
9.3 Labor Cost Analysis of Vascular Stent
9.4 Manufacturing Expenses Analysis of Vascular Stent
CHAPTER 10 MARKETING STATUS ANALYSIS OF VASCULAR STENT
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
1.1 Definition of Vascular Stent in This Report
1.2 Commercial Types of Vascular Stent
1.2.1 BMS
1.2.2 BVS
1.2.3 Drug Eluting
1.3 Downstream Application of Vascular Stent
1.3.1 Hospital
1.3.2 Cardiology Center
1.3.3 ASC
1.4 Development History of Vascular Stent
1.5 Market Status and Trend of Vascular Stent 2013-2023
1.5.1 Europe Vascular Stent Market Status and Trend 2013-2023
1.5.2 Regional Vascular Stent Market Status and Trend 2013-2023
CHAPTER 2 EUROPE MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of Vascular Stent in Europe 2013-2017
2.2 Consumption Market of Vascular Stent in Europe by Regions
2.2.1 Consumption Volume of Vascular Stent in Europe by Regions
2.2.2 Revenue of Vascular Stent in Europe by Regions
2.3 Market Analysis of Vascular Stent in Europe by Regions
2.3.1 Market Analysis of Vascular Stent in Germany 2013-2017
2.3.2 Market Analysis of Vascular Stent in United Kingdom 2013-2017
2.3.3 Market Analysis of Vascular Stent in France 2013-2017
2.3.4 Market Analysis of Vascular Stent in Italy 2013-2017
2.3.5 Market Analysis of Vascular Stent in Spain 2013-2017
2.3.6 Market Analysis of Vascular Stent in Benelux 2013-2017
2.3.7 Market Analysis of Vascular Stent in Russia 2013-2017
2.4 Market Development Forecast of Vascular Stent in Europe 2018-2023
2.4.1 Market Development Forecast of Vascular Stent in Europe 2018-2023
2.4.2 Market Development Forecast of Vascular Stent by Regions 2018-2023
CHAPTER 3 EUROPE MARKET STATUS AND FORECAST BY TYPES
3.1 Whole Europe Market Status by Types
3.1.1 Consumption Volume of Vascular Stent in Europe by Types
3.1.2 Revenue of Vascular Stent in Europe by Types
3.2 Europe Market Status by Types in Major Countries
3.2.1 Market Status by Types in Germany
3.2.2 Market Status by Types in United Kingdom
3.2.3 Market Status by Types in France
3.2.4 Market Status by Types in Italy
3.2.5 Market Status by Types in Spain
3.2.6 Market Status by Types in Benelux
3.2.7 Market Status by Types in Russia
3.3 Market Forecast of Vascular Stent in Europe by Types
CHAPTER 4 EUROPE MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Vascular Stent in Europe by Downstream Industry
4.2 Demand Volume of Vascular Stent by Downstream Industry in Major Countries
4.2.1 Demand Volume of Vascular Stent by Downstream Industry in Germany
4.2.2 Demand Volume of Vascular Stent by Downstream Industry in United Kingdom
4.2.3 Demand Volume of Vascular Stent by Downstream Industry in France
4.2.4 Demand Volume of Vascular Stent by Downstream Industry in Italy
4.2.5 Demand Volume of Vascular Stent by Downstream Industry in Spain
4.2.6 Demand Volume of Vascular Stent by Downstream Industry in Benelux
4.2.7 Demand Volume of Vascular Stent by Downstream Industry in Russia
4.3 Market Forecast of Vascular Stent in Europe by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF VASCULAR STENT
5.1 Europe Economy Situation and Trend Overview
5.2 Vascular Stent Downstream Industry Situation and Trend Overview
CHAPTER 6 VASCULAR STENT MARKET COMPETITION STATUS BY MAJOR PLAYERS IN EUROPE
6.1 Sales Volume of Vascular Stent in Europe by Major Players
6.2 Revenue of Vascular Stent in Europe by Major Players
6.3 Basic Information of Vascular Stent by Major Players
6.3.1 Headquarters Location and Established Time of Vascular Stent Major Players
6.3.2 Employees and Revenue Level of Vascular Stent Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 VASCULAR STENT MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 Medtronic
7.1.1 Company profile
7.1.2 Representative Vascular Stent Product
7.1.3 Vascular Stent Sales, Revenue, Price and Gross Margin of Medtronic
7.2 Abbott Laboratories
7.2.1 Company profile
7.2.2 Representative Vascular Stent Product
7.2.3 Vascular Stent Sales, Revenue, Price and Gross Margin of Abbott Laboratories
7.3 Boston Scientific Corporation
7.3.1 Company profile
7.3.2 Representative Vascular Stent Product
7.3.3 Vascular Stent Sales, Revenue, Price and Gross Margin of Boston Scientific Corporation
7.4 BIOTRONIK
7.4.1 Company profile
7.4.2 Representative Vascular Stent Product
7.4.3 Vascular Stent Sales, Revenue, Price and Gross Margin of BIOTRONIK
7.5 B. Braun Melsungen
7.5.1 Company profile
7.5.2 Representative Vascular Stent Product
7.5.3 Vascular Stent Sales, Revenue, Price and Gross Margin of B. Braun Melsungen
7.6 Terumo Corporation
7.6.1 Company profile
7.6.2 Representative Vascular Stent Product
7.6.3 Vascular Stent Sales, Revenue, Price and Gross Margin of Terumo Corporation
7.7 STENTYS
7.7.1 Company profile
7.7.2 Representative Vascular Stent Product
7.7.3 Vascular Stent Sales, Revenue, Price and Gross Margin of STENTYS
7.8 MicroPort Scientific Corporation
7.8.1 Company profile
7.8.2 Representative Vascular Stent Product
7.8.3 Vascular Stent Sales, Revenue, Price and Gross Margin of MicroPort Scientific Corporation
7.9 Meril Life Sciences
7.9.1 Company profile
7.9.2 Representative Vascular Stent Product
7.9.3 Vascular Stent Sales, Revenue, Price and Gross Margin of Meril Life Sciences
7.10 Vascular Concepts
7.10.1 Company profile
7.10.2 Representative Vascular Stent Product
7.10.3 Vascular Stent Sales, Revenue, Price and Gross Margin of Vascular Concepts
7.11 W. L. Gore and Associates
7.11.1 Company profile
7.11.2 Representative Vascular Stent Product
7.11.3 Vascular Stent Sales, Revenue, Price and Gross Margin of W. L. Gore and Associates
7.12 C. R. Bard
7.12.1 Company profile
7.12.2 Representative Vascular Stent Product
7.12.3 Vascular Stent Sales, Revenue, Price and Gross Margin of C. R. Bard
7.13 Endologix
7.13.1 Company profile
7.13.2 Representative Vascular Stent Product
7.13.3 Vascular Stent Sales, Revenue, Price and Gross Margin of Endologix
7.14 Lombard Medical Technologies
7.14.1 Company profile
7.14.2 Representative Vascular Stent Product
7.14.3 Vascular Stent Sales, Revenue, Price and Gross Margin of Lombard Medical Technologies
7.15 Translumina
7.15.1 Company profile
7.15.2 Representative Vascular Stent Product
7.15.3 Vascular Stent Sales, Revenue, Price and Gross Margin of Translumina
7.16 JOTEC
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF VASCULAR STENT
8.1 Industry Chain of Vascular Stent
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF VASCULAR STENT
9.1 Cost Structure Analysis of Vascular Stent
9.2 Raw Materials Cost Analysis of Vascular Stent
9.3 Labor Cost Analysis of Vascular Stent
9.4 Manufacturing Expenses Analysis of Vascular Stent
CHAPTER 10 MARKETING STATUS ANALYSIS OF VASCULAR STENT
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
